Improved Treatment Outcome with Haloperidol Decanoate and Amantadine in an Adolescent with Schizoaffective Disorder

J Child Adolesc Psychopharmacol. 2023 Oct;33(8):337-341. doi: 10.1089/cap.2023.29247.bjc.

Authors

Michelle Zaydlin^{1

2}, Julia A Bernal³, Yasin Bez^{1

2}, Barbara J Coffey^{1

2}

Affiliations

¹ Department of Psychiatry, University of Miami Miller School of Medicine, Miami, Florida, USA.
² Department of Psychiatry, Jackson Health System, Miami, Florida, USA.
³ University of Miami Miller School of Medicine, Miami, Florida, USA.

PMID: 37861989
DOI: 10.1089/cap.2023.29247.bjc

No abstract available

MeSH terms

Adolescent
Amantadine / therapeutic use
Antipsychotic Agents* / therapeutic use
Haloperidol / therapeutic use
Humans
Psychotic Disorders* / drug therapy
Treatment Outcome

Substances

haloperidol decanoate
Haloperidol
Amantadine
Antipsychotic Agents